Abstract:Ping Zhang, Yanan Cai, Fei Ge, Zunmin Zhu, Kai Sun Department of Hematology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, People's Republic of China Correspondence: Kai Sun, Department of Hematology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, &num7 Weiwu Road, Zhengzhou, People's Republic of China, Email Introduction: This study aims to investigate the incidence, clinical characteristics, and prognosis of thrombosis in Chinese patients with immune thrombocytopenia (ITP). Methods: This was a single-center, retrospective study of adult patients with ITP at the Henan Provincial People's Hospital from January 2018 to June 2023. Results: A total of 3216 adult patients with primary ITP were included in the study period, with 25 (0.93%) having thrombotic events. The average age of 25 patients with thrombosis is 62.76± 12.79 years, including 11 males and 14 females. In addition, among the 25 thrombotic events, 19 cases were arterial thrombosis (AT), and 6 cases were venous thrombosis (VT). The incidence of AT is higher than that of VT (P=0.009). There was no obvious difference in clinical characteristics between the two groups. The median platelet count at the time of thrombosis in 25 patients was 35 (23, 52) × 10 9 /L. At the onset of thrombosis, 23 patients (92.0%) had a low PLT (< 100× 10 9 /L). One patient with ischemic stroke died in the hospital due to severe infection. Conclusion: ITP may be considered a bleeding disorder with a high risk of thrombosis, and AT is more common than VT in the Chinese population. Keywords: immune thrombocytopenia, arterial thrombosis, venous thrombosis, platelet, hemorrhagic disease Immune thrombocytopenia (ITP) is an autoimmune condition marked by autoantibody-induced platelet destruction and attenuated thrombopoiesis, which results in a decreased platelet count. (<100 × 10 9 /L). 1,2 ITP may be primary, which means there is no known underlying cause, or secondary to other diseases, such as autoimmune disease, infection, malignancy, or post-vaccine. 3 ITP is a common hemorrhagic disease in clinical practice. However, in recent years, it has also been noted that ITP patients have an elevated risk of thromboembolic events. 4–9 Using the Danish National Patient Registry, the incidence rate of venous thrombosis (VT) and arterial thrombosis (AT) in the ITP cohort was 0.53 and 1.14 per 100 person-years, respectively, higher than that in the general population. 4,5 According to the meta-analysis of an observational study, patients with ITP had nearly double the rate of VT and a 50% higher rate of AT than people in the general population. 9 In these cases, AT occurs more frequently than VT. ITP complicated with thrombosis has a complex etiology. The occurrence of thrombosis in ITP patients is an unexpected discovery that poses significant challenges for ITP treatment. Balancing the risk of bleeding and thrombosis has become crucial for these patients. Nowadays, there is limited clinical data on ITP combined with thromboembolism in the Chinese population. The purpose of this study is to investigate the incidence, clinical characteristics, and prognosis of thrombosis in Chinese ITP patients. Adult patients (≥18 years old) with ITP were included in this single-center, retrospective study at the Henan Provincial People's Hospital from January 2018 to June 2023. In our hospital's digital medical records, we looked for individuals who had been given an "immune thrombocytopenia" or "idiopathic thrombocytopenic purpura" diagnosis. Patients with secondary ITP were not included in this study. This research was approved by the Ethics Committee of the Henan Provincial People's Hospital. In addition, written informed consent was obtained from each participant at their enrollment. This study was performed in line with the principles of the Declaration of Helsinki. Clinical information was obtained from the Henan Provincial People's Hospital's Medical Information Recording System. The information gathered included: demographic data (age and gender), medical history (diabetes mellitus, hypertension, coronary artery disease, stroke), laboratory data, ITP treatment strategies (glucocorticoids, recombinant human thrombopoietin (rhTPO), intravenous immunoglobulin (IVIG), and platelet transfusion), and clinical characteristics. Primary ITP was diagnosed according to the universal definition. 1,10 Primary ITP is an autoimmune disorder characterized by isolated thrombocytopenia (peripheral blood platelet count <100 × 10 9 /L) in the absence of other causes or disorders that may be associated with thrombocytopenia. Secondary ITP was def -Abstract Truncated-

Analysis of 110 cases of thrombocytopenia in human immunodeficiency virus infection/acquired immunodeficiency syndrome patients

Clinical features and treatment effect of HIV-associated immune thrombocytopenia—single center Ten-Years data summary

The Impact of Highly Active Antiretroviral Treatment on the Blood Profiles of Patients with Acquired Immune Deficiency Syndrome

HIV-Associated Thrombotic Thrombocytopenic Purpura in a Virally Suppressed Patient With Normal CD4 Count: A Rare Presentation

Clinical analysis on one patient with hemophilia A complicated with primary immune thrombocytopenia

Transfusion-Associated HIV Infection in Pediatric Leukemia Patients (two Case Reports).

The causes of death for 89 HIV/AIDS patients

Study on the application of CD4+ T lymphocyte rapid detection method in treating AIDS

A Cross-Sectional Study of Leukopenia and Thrombocytopenia among Chinese Adults with Newly Diagnosed Hiv/Aids

Expression of CD127 of T lymphocytes in peripheral blood of patients with HIV-1/AIDS and its clinical significance

Four years clinical analysis of 50 cases of hemophilia patients co-infected by AIDS/HCV treated with active antiretroviral therapy

Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases

Clinical Characteristics of HIV-Infected Patients with Venous Thromboembolism and Different CD4+ T Lymphocyte Levels

The Factors Related To Cd4+T-Cell Recovery And Viral Suppression In Patients Who Have Low Cd4+T Cell Counts At The Initiation Of Haart: A Retrospective Study Of The National Hiv Treatment Sub-Database Of Zhejiang Province, China, 2014

Prevalence and Influencing Factors of Thyroid Dysfunction in HIV-Infected Patients.

Hematological abnormalities in HIV-infected patients

Profile of HIV-1 Infected Patients from an AIDS Clinic in Beijing from 2007-2008

Renal Pathology and clinical features of patients with human immunodeficiency virus infection complicated with kidney diseases

Clinical epidemiology of 359 cases of acquired immunodeficiency syndrome and pulmonary tuberculosis co-infection

Biological characteristics and survival analysis in HIV/HCV co-infected patients

The Incidence and Characteristics of Thrombosis in Patients with Immune thrombocytopenia: A Retrospective Cohort Study